Fortress Biotech Inc (FRA:CNB1)
€ 4.131 0 (0%) Market Cap: 32.09 Mil Enterprise Value: 30.08 Mil PE Ratio: 0 PB Ratio: 2.19 GF Score: 62/100

Fortress Biotech Inc at SNN Network Virtual Conference Transcript

Aug 05, 2020 / 05:00PM GMT
Release Date Price: €35.4 (-1.67%)
Operator

Greetings, and welcome to the Fortress Biotech conference. It is now my pleasure to introduce your host, Dr. Lindsay Rosenwald, CEO of Fortress Biotech. Thank you, Dr. Rosenwald. You may begin.

Lindsay Allan Rosenwald
Fortress Biotech, Inc. - Executive Chairman, President & CEO

Thank you, Paul. Good afternoon, everybody. It's a pleasure to present to you today at the SNN virtual conference, and it certainly is virtual. You can't see me, I can't see you. It's starting to get long in the tooth. Can't wait to get back to reality. But in the meantime, it's a pleasure.

We'll be making some forward-looking statements today. Feel free to look at our SEC filings for all of our detailed financial information and risk factors.

So I usually like to start with what the opportunity is as a potential investor in Fortress. We have a lot of near-term key catalysts that we believe can create value opportunities. We have a very robust pipeline with 25 or more development stage biotech and pharmaceutical product candidates. I like to think we so far have a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot